Nuveen Asset Management, LLC - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 129 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q2 2024$3,958,709
-56.3%
352,512
-51.7%
0.00%
-66.7%
Q1 2024$9,066,584
-25.6%
730,587
-16.2%
0.00%
-25.0%
Q4 2023$12,184,396
-58.2%
871,559
-55.8%
0.00%
-60.0%
Q3 2023$29,153,853
+130.1%
1,973,856
+101.3%
0.01%
+150.0%
Q2 2023$12,669,003
+253991.5%
980,573
+92.9%
0.00%
+100.0%
Q1 2023$4,986
-49.8%
508,242
-45.6%
0.00%
-50.0%
Q4 2022$9,935
-99.9%
933,787
-34.4%
0.00%
-33.3%
Q3 2022$14,858,000
-17.9%
1,423,233
-1.0%
0.01%
-14.3%
Q2 2022$18,106,000
+19.2%
1,438,176
+8.0%
0.01%
+40.0%
Q1 2022$15,190,000
-21.3%
1,331,300
-3.0%
0.01%
-16.7%
Q4 2021$19,311,000
-3.2%
1,372,501
+32.2%
0.01%0.0%
Q3 2021$19,948,000
+180.8%
1,038,451
+44.0%
0.01%
+200.0%
Q2 2021$7,103,000
+53.3%
721,046
+53.0%
0.00%
+100.0%
Q1 2021$4,632,000
+163.5%
471,179
+19.2%
0.00%0.0%
Q4 2020$1,758,000
+5.3%
395,192
+2.3%
0.00%0.0%
Q3 2020$1,669,000
-45.5%
386,253
+11.8%
0.00%0.0%
Q2 2020$3,065,000
+196.7%
345,540
+18.1%
0.00%0.0%
Q1 2020$1,033,000
-37.7%
292,587
+0.8%
0.00%0.0%
Q4 2019$1,659,000
+54.8%
290,189
-3.2%
0.00%
Q3 2019$1,072,000
+10.6%
299,855
+23.5%
0.00%
Q2 2019$969,000242,8840.00%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 10,895,773$47,070,0004.39%
DC Investments Management, LLC 196,799$850,0000.93%
Chicago Capital, LLC 3,930,524$16,980,0000.87%
PFM Health Sciences, LP 2,936,990$12,688,0000.59%
Avidity Partners Management LP 2,025,000$8,748,0000.41%
Soleus Capital Management, L.P. 167,798$725,0000.38%
Rhenman & Partners Asset Management AB 925,534$3,998,0000.36%
Haafor (Singapore) Pte. Ltd. 27,128$117,0000.24%
JACKSON SQUARE CAPITAL, LLC 122,555$529,0000.23%
Parkman Healthcare Partners LLC 200,000$864,0000.23%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders